Ad is loading...
LIVN
Price
$51.70
Change
+$1.65 (+3.30%)
Updated
Nov 21 closing price
89 days until earnings call
NEO
Price
$15.39
Change
+$0.03 (+0.20%)
Updated
Nov 21 closing price
95 days until earnings call
Ad is loading...

LIVN vs NEO

Header iconLIVN vs NEO Comparison
Open Charts LIVN vs NEOBanner chart's image
LivaNova
Price$51.70
Change+$1.65 (+3.30%)
Volume$585.26K
CapitalizationN/A
NeoGenomics
Price$15.39
Change+$0.03 (+0.20%)
Volume$454.5K
CapitalizationN/A
LIVN vs NEO Comparison Chart
Loading...
LIVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
LIVN vs. NEO commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIVN is a Buy and NEO is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (LIVN: $51.70 vs. NEO: $15.39)
Brand notoriety: LIVN and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LIVN: 125% vs. NEO: 56%
Market capitalization -- LIVN: $3.02B vs. NEO: $2.01B
LIVN [@Medical Specialties] is valued at $3.02B. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIVN’s FA Score shows that 0 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • LIVN’s FA Score: 0 green, 5 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, NEO is a better buy in the long-term than LIVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIVN’s TA Score shows that 5 TA indicator(s) are bullish while NEO’s TA Score has 5 bullish TA indicator(s).

  • LIVN’s TA Score: 5 bullish, 4 bearish.
  • NEO’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, LIVN is a better buy in the short-term than NEO.

Price Growth

LIVN (@Medical Specialties) experienced а -1.19% price change this week, while NEO (@Medical Specialties) price change was -2.53% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.47%. For the same industry, the average monthly price growth was -1.10%, and the average quarterly price growth was -2.69%.

Reported Earning Dates

LIVN is expected to report earnings on Feb 19, 2025.

NEO is expected to report earnings on Feb 25, 2025.

Industries' Descriptions

@Medical Specialties (+0.47% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIVN($3.02B) has a higher market cap than NEO($2.01B). LIVN has higher P/E ratio than NEO: LIVN (172.28) vs NEO (49.50). LIVN YTD gains are higher at: -0.077 vs. NEO (-4.883). LIVN has higher annual earnings (EBITDA): 38.5M vs. NEO (-17.61M). NEO has more cash in the bank: 415M vs. LIVN (267M). NEO (612M) and LIVN (640M) have identical debt. LIVN has higher revenues than NEO: LIVN (1.15B) vs NEO (592M).
LIVNNEOLIVN / NEO
Capitalization3.02B2.01B150%
EBITDA38.5M-17.61M-219%
Gain YTD-0.077-4.8832%
P/E Ratio172.2849.50348%
Revenue1.15B592M195%
Total Cash267M415M64%
Total Debt640M612M105%
FUNDAMENTALS RATINGS
LIVN vs NEO: Fundamental Ratings
LIVN
NEO
OUTLOOK RATING
1..100
6115
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8791
PRICE GROWTH RATING
1..100
5750
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (69) in the Medical Or Nursing Services industry is in the same range as LIVN (82) in the Medical Specialties industry. This means that NEO’s stock grew similarly to LIVN’s over the last 12 months.

NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as LIVN (100) in the Medical Specialties industry. This means that NEO’s stock grew similarly to LIVN’s over the last 12 months.

LIVN's SMR Rating (87) in the Medical Specialties industry is in the same range as NEO (91) in the Medical Or Nursing Services industry. This means that LIVN’s stock grew similarly to NEO’s over the last 12 months.

NEO's Price Growth Rating (50) in the Medical Or Nursing Services industry is in the same range as LIVN (57) in the Medical Specialties industry. This means that NEO’s stock grew similarly to LIVN’s over the last 12 months.

NEO's P/E Growth Rating (100) in the Medical Or Nursing Services industry is in the same range as LIVN (100) in the Medical Specialties industry. This means that NEO’s stock grew similarly to LIVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LIVNNEO
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 15 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
LIVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PABWX18.970.28
+1.50%
Principal MidCap Value I R4
PRBLX66.530.59
+0.89%
Parnassus Core Equity Investor
HSUTX64.990.26
+0.40%
Rational Dynamic Brands Instl
GIXIX8.860.02
+0.23%
Nationwide International Index R6
FIRTX9.03-0.02
-0.22%
Fidelity Advisor Intl Real Estate M

LIVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIVN has been loosely correlated with SRDX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LIVN jumps, then SRDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIVN
1D Price
Change %
LIVN100%
+3.30%
SRDX - LIVN
38%
Loosely correlated
+0.05%
ALGN - LIVN
34%
Loosely correlated
+1.94%
NEO - LIVN
33%
Poorly correlated
+0.20%
AVNS - LIVN
33%
Poorly correlated
+0.84%
UFPT - LIVN
32%
Poorly correlated
+2.01%
More